Cell & Gene Therapies: A guide to single-use fluid connections
The pharmaceutical industry has proven it can successfully develop cell and gene therapies (CGTs). CGTs have many of the same manufacturing needs as biopharmaceuticals. Industry experts expect single-use technologies (SUTs) used in biopharmaceutical clinical trials and commercial production will play a large role in the future development and production of CGTs.
Our guide can help you:
- Discover how bioprocessing and CGT processes are similar and different
- Learn if today’s cell therapy manufacturing processes are adequate for commercialization
- Understand what to consider when choosing a fluid connection technology
Download Cell & Gene Therapies: A guide to single-use connections – 10 transferable lessons from the bioprocessing industry to learn more.